Medicine

All Articles

Safety and antiviral effect of a three-way combination of HIV-1 extensively reducing the effects of antibodies: a stage 1\/2a trial

.Study designThe study assessed the safety and security, pharmacokinetics and antiviral activity of ...

Prenatal exposure to famine affects lifetime wellness

.Nature Medication, Published online: 09 September 2024 doi:10.1038/ d41591-024-00068-4Analysis of i...

A worldwide metric of immune health

.Attribute Medication, Released online: 05 September 2024 doi:10.1038/ s41591-024-03210-4A research ...

Niacin, food items intake as well as heart impacts

.Attribute Medication, Published online: 05 September 2024 doi:10.1038/ s41591-024-03220-2Niacin, fo...

Opportunities as well as problems for patient-reported end result examination in multimorbidity research study as well as method

.Competing passions.S.E.H. acquires financing from the National Principle of Health and also Care Re...

Hibernation scientific research utilized to manage weight problems and also customize metabolic process

.Attributes Medicine, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy understandi...

CAR- T and also cellular genetics therapies are actually also costly

.Nature Medication, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care ma...

The that genomics program of work with reasonable implementation of individual genomics for global wellness

.The magazine of the initial draft of the human genome sequence in 20011 was followed due to the int...

A time-stratified, case\u00e2 $ \"crossover study of heat exposure and perinatal death coming from 16 hospitals in sub-Saharan Africa

.One of 138,015 hospital-based singleton childbirths in four sub-Saharan African countries, we obser...

Advancing international antibiotic research study, growth and also get access to #.\n\nMurray, C. J. L. et al. Worldwide worry of microbial antimicrobial resistance in 2019: a systematic study. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Frontrunnerses. In the direction of details dedications and activity in the action to antimicrobial protection. International Leaders Team on Antimicrobial Resistance https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). Planet Health And Wellness Organization. WHO releases checklist of germs for which brand new anti-biotics are actually urgently required. World Health and wellness Company https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). World Wellness Company. WHO bacterial top priority pathogens list, 2024: bacterial pathogens of hygienics relevance to lead investigation, growth and also methods to avoid and regulate antimicrobial resistance. Planet Wellness Organization https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt approach to Gram-negative access. Bioorg. Med. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic protection. Ups. J. Med. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle Scholar\u00c2.\nWorld Health And Wellness Organization. 2023 antibacterial representatives in clinical as well as preclinical progression: a summary and analysis. Globe Health Company https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et cetera. AMR Evaluation. May 19, 2016 \u00e2 $\" Addressing drug-resistant infections internationally: final document and also suggestions. Review on Antimicrobial Protection https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Range. DRIVE-AB outputs: files as well as rundown. Drive AB https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et cetera. Appearing the wall: an ask for collective action on anti-biotics r &amp d. Boston ma Consulting Group https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Plan Short 51: Just how can the EU support sustainable development as well as access to efficient antibiotics? plan possibilities for existing and new medications. International Observatory on Health Solutions and also Policies https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Antibiotic usage as well as resistance\u00e2 $\" verifying the apparent. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nPlanet Health And Wellness Association. 2021 AWaRe distinction. That get access to, watch, get, distinction of anti-biotics for examination as well as tracking of use. Planet Wellness Institution https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). European Facility for Illness Deterrence and also Command. Antimicrobial protection targets: how can our team reach all of them through 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). Globe Health Company. Shortage of development set to weaken antibiotic functionality and health and wellness increases. Globe Health Association https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et cetera. How antimicrobial protection is connected to climate modification: a summary of two linked international problems. Int. J. Environ. Res. Hygienics twenty, 1681 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant bacterial contaminations: our team need critical action as well as expenditure that concentrate on the weakest hyperlink. PLoS Biol. 20, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nGlobe Health And Wellness Company. Booster shot protection. World Wellness Association https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Contamination avoidance and control in low-resource setups: the need for the local, the contextual as well as the practical. Corrupt. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Obstacles of implementing antimicrobial conservation devices in reduced to middle income countries (LMICs). Contaminate. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nAminov, R. A brief history of the antibiotic era: courses found out as well as difficulties for the future. Face. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K. et al. Individual accessibility in 14 high-income countries to new antibacterials accepted by the United States Food and Drug Administration, European Medicines Company, Japanese Pharmaceuticals as well as Medical Instruments Organization, or Health Canada, 2010\u00e2 $ \"2020. Clin. Contaminate. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nGlobe Wellness Organization. 2021 anti-bacterial brokers in medical and preclinical progression: an outline and review. Globe Health and wellness Company https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Prescription antibiotics: the business economics should sustain the science. Attribute 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The condition of development in anti-bacterial rehabs. Medical Development Institution https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et cetera. Examining clinician usage of next-generation prescription antibiotics versus immune Gram-negative diseases in united state hospitals: a retrospective mate research. Ann. Trainee. Med. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nThomas, D. &amp Wessel, C. The state of development in antibacterial therapeutics. Medical Advancement Institution https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. An organized evaluation and also vital analysis of motivation tactics for revelation as well as advancement of unique antibiotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle Scholar\u00c2.\nWellness Emergency Situation Preparedness and also Action Authorization. Research and development of health care countermeasures. European Payment https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). European Compensation. Pre-draft proposal for an International partnership under Horizon Europe One Health Antimicrobial Resistance. International Percentage https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). Global Anti-biotic Experimentation Collaboration. Entasis Therapies and also the Worldwide Anti-biotic Research Study &amp Advancement Relationship to establish a brand-new procedure for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of field- as well as non-industry-sponsored scientific trials. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nGlobe Health Institution. Amount of medical trial signs up by site, condition, stage of progression, grow older as well as sex of test attendees (1999\u00e2 $ \"2022). Globe Wellness Association https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). Worldwide Antibiotic Research and Development Partnership. NeoSept1: a research to establish the rank of existing and also new prescription antibiotics mixes to deal with newborns that reside in medical facility with extreme blood poisoning. ISRCTN registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Hygienics Company of Canada. Government of Canada brings in vital investment to overcome antimicrobial resistance (AMR), Authorities of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). International Prescription Antibiotic Experimentation Relationship. Japan federal government backing assists GARDP\u00e2 $ s initiatives to resist antibiotic protection. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 October 2023). Novo Nordisk Groundwork. Novo Nordisk Groundwork partners along with CARB-X to overcome drug-resistant diseases. novo nordisk structure https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). European Commission: European Health And Wellness and Digital Executive Company. Research study on delivering AMR health care countermeasures to the market place. Publications Workplace of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Approximating the suitable dimension of global pull rewards for anti-bacterial medications. Health and wellness Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Dimensions a market entry perks for the development of new prescription antibiotics. Harvard Kennedy School https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et cetera. Sector incentives and also antibiotic protection: an introduction to the antibiotic susceptibility bonus. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nBonnifield, R. &amp Towse, A. An ambitious USG advanced commitment for subscription-based purchasing of unfamiliar antimicrobials and its assumed roi. Facility for Global Advancement https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 Nov 2022). Towse, A. &amp Silverman Bonnifield, R. G7 expenditures in new prescription antibiotics would pay off \u00e2 $\" for everybody. Office of Health Economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS improves struggle against severe contaminations observing effective world-first aviator. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). United States Our lawmakers. S. 1355 \u00e2 $\" PASTEUR Process of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). European Commission. Reform of the EU pharmaceutical legalisation. International Compensation https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et al. Repayment models to tackle market failures for antimicrobials: techniques absorbed France, Germany, Sweden, the UK, and also the USA. Health and wellness Policy 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nInternational Federation of Pharmaceutical Manufacturers as well as Organizations. Coming from resistance to strength: what could the future antibiotic pipe seem like? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). International AMR R&ampD Center &amp Planet Wellness Company. Incentivising the progression of new anti-bacterial therapies: 2023 report card due to the International AMR R&ampD Center and also That. Worldwide AMR R&ampD Hub https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Singer, A., Roberts, A. P. &amp Kirchhelle, C. Why is actually the UK subscription version for anti-biotics taken into consideration prosperous? Lancet Micro organism 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNon-paper \u00e2 $\" unfamiliar stimulations for the progression and also keeping the market place of antimicrobials. Politico https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et cetera. Global, local, and also national reasons for youngster death in 2000\u00e2 $ \"13, with forecasts to update post-2015 priorities: an updated systematic review. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nQuadri, F. et cetera. Antibacterial medication lacks from 2001 to 2013: implications for professional practice. Clin. Affect. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nBenhabib, A. et al. The French coverage device for drug scarcities: explanation and also patterns coming from 2012 to 2018: an empirical retrospective research study. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nKlein, E. Y. et cetera. Evaluation of WHO antibiotic intake and access aim ats in 76 countries, 2000\u00e2 $ \"15: an evaluation of pharmaceutical purchases data. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Dealing with the fakes: tackling subpar and also falsified medicines. Nat. Rev. Dis. Guides 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it obtaining easier to acquire antibiotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nAfrican Culture for Lab Medication. Policy short and also infographics on antimicrobial protection (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et cetera. National antibiotic usage for human usage in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional research study. Trop. Med. Affect. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nNamugambe, J. S. et cetera. National antimicrobial intake: analysis of core storage facilities products to in-patient care health amenities from 2017 to 2019 in Uganda. Trop. Med. Contaminate. Dis. 6, 83 (2021 ).\nGoogle Scholar\u00c2.\nRobertson, J. et cetera. Variants in the consumption of antimicrobial medications in the European area, 2014\u00e2 $ \"2018: searchings for and ramifications from ESAC-Net and also That Europe. Front. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nShukar, S. et cetera. Drug shortage: sources, effect, as well as reduction approaches. Front end. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Patient access in 14 high-income countries to new antibacterials approved due to the United States Fda, European Medicines Company, Japanese Pharmaceuticals and also Medical Instruments Organization, or Health And Wellness Canada, 2010\u00e2 $ \"2020. Clin. Corrupt. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nPulcini, C. et al. Wasted anti-biotics: a follow-up stock study in Europe, the USA, Canada and Australia. Int. J. Antimicrob. Agents 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted wellness innovation for global wellness. Br. Medication. J. 366, 15601 (2019 ).\nGoogle.com Scholar\u00c2.\nAMR Field Alliance. The 2023 AMR Field Partnership progress survey: production and also the atmosphere. amr Industry Collaboration https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Invasion, D. &amp Gaule, P. Can health care products be actually built on a non-profit basis? Looking into product development relationships for neglected conditions. Sci. Public law 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nSwaminathan, S. et cetera. Restart biomedical R&ampD in the global public rate of interest. Attribute 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nAfrica Centres for Health Condition Command and Protection. Africa CDC initiates vibrant relocate to get Africa\u00e2 $ s wellness future by creating a 50 billion dollar health care market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Blood, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Arranging public-health trademark licensing arrangements to boost access to health innovations: an insider\u00e2 $ s account. BMJ Chunk. Health 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New business models for trial and error along with price needs are actually needed to attain fair prices of medications. Br. Med. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nCombating Antibiotic-Resistant Micro-organisms Biopharmaceutical Gas. Stewardship as well as accessibility. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). Global Antibiotic Experimentation Relationship. Shinogi, GARDP as well as CHAI reveal landmark permit and cooperation contracts to manage bacterial diseases next to broadening accessibility to cefiderocol in 135 nations. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Field Collaboration. Leaving the lab: tracking the decrease in AMR R&ampD professionals. amr Market Partnership https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Health And Wellness Ministers. G7 Health Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (twenty May 2022). G20. G20 contact us to action on antimicrobial protection. G7G20 Files Data bank https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 Oct 2022). International Coalition on Aging &amp Infectious Health Conditions Culture of The United States. 2024 AMR preparedness mark progress report. Assessing authorities activity on AMR policy. Global Union on Aging https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Food Items and Agriculture Association of the United Nations, United Nations Atmosphere Programme, World Wellness Company &amp. Planet Organization for Pet Health And Wellness. Global data bank for tracking antimicrobial resistance (AMR): nation self-assessment questionnaire (TrACSS). That https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Vehicle Katwyk, S. R. &amp Outterson K. Introduction: AMR belongs in ...